May’s top news stories

Abivax unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human immunodeficiency virus (HIV). Credit: Shutterstock.

nurse talking, making notes

Cancer Research UK Clinical Trials Unit at the University of Birmingham started a Phase I trial for leukaemia. Credit: Cancer Research UK.

A healthy volunteer received an IV infusion of mAb114. Credit: NIAID.